The stimulation of SREBP1c due to insulin resistance and hyperglycemia increases the rate of de novo fatty acid synthesis through activation of lipogenic enzymes such as fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC) [10]. Here, INS is linked to Hyperglycemia.